BFNH Bioforce Nanosciences Holdings, Inc.
Fundamentals / CIK 0001310488 / USDBioforce Nanosciences Holdings, Inc. reported $786 in total assets and a net loss of $323K through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BFNH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-- Operating profit
-
Net Income FY 2025-$323K GAAP bottom line
-
Diluted EPS FY 2025-$0.01 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Dec 31, 2026$786 Total debt: --
Annual revenue and net income
9 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | $18K | $16K | $4.5K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $13K | $12K | $3.2K |
| Gross Profit | -- | -- | -- | -- | -- | -- | $4.4K | $4.7K | $1.3K |
| Total Operating Expenses | $490K | $490K | $472K | $486K | $502K | $158.4M | $51K | -- | -- |
| Operating Income | -- | -- | -- | -- | -- | -- | -$47K | -$67K | -$31K |
| Income Before Tax | -$490K | -$490K | -- | -- | -- | -- | -$47K | -$68K | -$31K |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | $0 | $0 | -- |
| Net Income | -$1.29M | -$490K | -$472K | -$486K | -$502K | -$158.4M | -$47K | -$68K | -$31K |
| Basic EPS | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M | 16.3M | 15.3M | 15.3M | 76.2M |
| Diluted Shares Outstanding | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M | 16.3M | 15.3M | 15.3M | 76.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Operating Expenses | $342K | $262K | $118K | $118K | $116K | $123K | $133K | $123K |
| Operating Income | -$342K | -$763K | -$133K | -- | -$116K | -$123K | -$133K | -- |
| Income Before Tax | -$342K | -$262K | -$118K | -$118K | -$116K | -$123K | -$133K | -- |
| Net Income | -$342K | $239K | -$102K | -$118K | -$116K | -$123K | -$935K | -$123K |
| Basic EPS | -$0.01 | $0.01 | $0.00 | -- | $0.00 | $0.00 | -$0.03 | -- |
| Diluted EPS | -$0.01 | $0.01 | $0.00 | -- | $0.00 | $0.00 | -$0.03 | -- |
| Basic Shares Outstanding | 35.0M | 33.5M | 33.5M | -- | 33.5M | 33.5M | 32.2M | -- |
| Diluted Shares Outstanding | 35.0M | 33.5M | 33.5M | -- | 33.5M | 33.5M | 32.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $786 | $862 | $638 | $734 | $11K | $40K | $53K | $29K | $14K |
| Cash & Short-Term Investments | $786 | $862 | $638 | $734 | $11K | $40K | $53K | $29K | $14K |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $5.7K | $4.5K |
| Total Current Assets | $786 | $862 | $638 | $734 | $11K | $40K | $59K | $35K | $21K |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $786 | $862 | $638 | $734 | $11K | $40K | $59K | $35K | $21K |
| Total Current Liabilities | $619K | $2.30M | $1.82M | $1.35M | $873K | $400K | $12K | $5.3K | $13K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $619K | $2.30M | $1.82M | $1.35M | $873K | $400K | $12K | $5.3K | $13K |
| Common Stock | $34K | $29K | $29K | $29K | $29K | $29K | $15K | $15K | $76K |
| Retained Earnings | -$162.4M | -$161.1M | -$160.6M | -$160.2M | -$159.7M | -$159.2M | -$762K | -$715K | -$647K |
| Total Stockholders' Equity | -$619K | -$2.30M | -$1.82M | -$1.35M | -$862K | -$360K | $47K | $30K | $8.2K |
| Total Equity | -$619K | -$2.30M | -$1.82M | -$1.35M | -$862K | -$360K | $47K | $30K | $8.2K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-12-31 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $786 | $32K | $307 | $6.3K | $786 | $784 | $905 | $14K |
| Cash & Short-Term Investments | $786 | $32K | $307 | $6.3K | $786 | $784 | $905 | $14K |
| Total Current Assets | $786 | $2.00M | $2.15M | $6.3K | $786 | $784 | $905 | $14K |
| Total Non-Current Assets | $0 | $235K | $235K | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $786 | $2.24M | $2.39M | $6.3K | $786 | $784 | $905 | $14K |
| Total Current Liabilities | $619K | $277K | $85K | $727K | $619K | $501K | $385K | $275K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $619K | $277K | $85K | $727K | $619K | $501K | $385K | $275K |
| Common Stock | $34K | $38K | $34K | $34K | $34K | $34K | $34K | $34K |
| Retained Earnings | -$162.4M | -$162.6M | -$162.3M | -$162.5M | -$162.4M | -$162.3M | -$162.2M | -$162.1M |
| Total Stockholders' Equity | -$619K | $1.96M | $2.30M | -$721K | -$619K | -$500K | -$384K | -$261K |
| Total Equity | -$619K | $1.96M | $2.30M | -$721K | -$619K | -$500K | -$384K | -$261K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.29M | -$490K | -$472K | -$486K | -$502K | -$158.4M | -$47K | -$68K | -$31K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $5.7K | -$1.2K | -$4.5K |
| Operating Cash Flow | -$65K | -$61K | -$47K | -$68K | -$78K | -$80K | -$24K | -$62K | -$26K |
| Financing Cash Flow | $65K | $61K | $47K | $58K | $49K | $67K | $48K | -- | -- |
| Net Change in Cash | -$76 | $224 | -$96 | -$10K | -$29K | -$13K | -- | -- | -- |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$342K | $239K | -$102K | -$118K | -$116K | -$123K | -$935K | -$123K |
| Operating Cash Flow | -$95K | -$27K | $7.1K | -$11K | -$11K | -$28K | -$15K | -$15K |
| Financing Cash Flow | $126K | $21K | -$1.5K | $11K | $11K | $15K | $28K | $14K |
| Net Change in Cash | $31K | -$6.0K | $5.6K | $2 | -$121 | -$13K | $13K | -$773 |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | 24.5% | 28.6% | 27.9% |
| Operating Margin | -- | -- | -- | -- | -- | -- | -261.8% | -409.2% | -694.7% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -261.8% | -415.3% | -694.7% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -98.4% | -227.3% | -381.1% |
| Return on Assets (ROA) | -164370.4% | -56895.2% | -73973.8% | -66146.3% | -4503.9% | -397362.5% | -79.0% | -192.8% | -149.5% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.10x | 5.08x | 6.60x | 1.65x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.10x | 4.57x | 6.60x | 1.48x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | +9.0% | +262.4% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -6.5% | +271.7% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -16.5% | -4.2% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -14.4% | -4.1% | -7230.3% | -164370.4% | -165473.6% | -144024.5% | -9385.3% | -56895.2% |
| Current Ratio | 7.23x | 25.41x | 0.01x | 0.00x | 0.00x | 0.00x | 0.05x | 0.00x |
| Quick Ratio | 0.11x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.05x | 0.00x |